• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病的病理学

The pathology of Gaucher disease.

作者信息

Lee R E

出版信息

Prog Clin Biol Res. 1982;95:177-217.

PMID:7122634
Abstract

Several features of Gaucher disease have been described related to an experience gained from a study of 275 patients. These include splenic nodules, a nodular form of cirrhosis affecting the liver of patients who have severe disease as well as unsuspected involvement of the brain. The anatomic distribution of Gaucher cells in the brain may be an age related phenomenon. Various types of involvement of the lungs can produce severe cyanosis or cor pulmonale according to the anatomic distribution of the Gaucher cells. The belief that bone disease can be produced by prior splenectomy was dispelled by a study of 239 patients with type I and type III disease. The reasons for the association of malignant tumors with older patients who have type I disease is not understood but should encourage careful follow-up of these patients. As we enter the second century of our knowledge of this disease we should keep Dr. Gaucher's talent of making careful clinicopathological observations in mind as we search for clues to the better understanding of the various clinical forms of the disease.

摘要

根据对275例患者的研究所得经验,已描述了戈谢病的几个特征。这些特征包括脾结节、一种影响重症患者肝脏的结节性肝硬化形式,以及脑部未被怀疑的受累情况。脑中戈谢细胞的解剖分布可能是一种与年龄相关的现象。根据戈谢细胞的解剖分布,肺部的各种受累类型可导致严重的发绀或肺心病。一项对239例I型和III型疾病患者的研究消除了认为脾切除术前会出现骨病的观点。I型疾病老年患者与恶性肿瘤相关联的原因尚不清楚,但这应促使对这些患者进行仔细的随访。当我们进入对这种疾病认识后的第二个世纪时,在我们寻找线索以更好地理解该疾病的各种临床形式时,应牢记高歇医生进行仔细临床病理观察的才能。

相似文献

1
The pathology of Gaucher disease.戈谢病的病理学
Prog Clin Biol Res. 1982;95:177-217.
2
MR imaging of patients with type 1 Gaucher's disease: relationship between bone and visceral changes.1型戈谢病患者的磁共振成像:骨骼与内脏变化之间的关系。
AJR Am J Roentgenol. 1995 Sep;165(3):599-604. doi: 10.2214/ajr.165.3.7645477.
3
LIver abnormalities in patients with Gaucher's disease.戈谢病患者的肝脏异常。
Gastroenterology. 1981 Jan;80(1):126-33.
4
[Gaucher's disease. Longitudinal-study in 17 patients in a 10-year period (1970-1980) (author's transl)].[戈谢病。1970年至1980年期间对17例患者的纵向研究(作者译)]
Pediatr Med Chir. 1981 Nov-Dec;3(6):487-94.
5
Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.1型戈谢病患者的生长和青春期延迟:自然病史以及脾切除术和/或酶替代疗法的影响
Isr Med Assoc J. 2000 Feb;2(2):158-63.
6
Gaucher's disease: clinical, morphologic, and pathogenetic considerations.戈谢病:临床、形态学及发病机制方面的考量
Pathol Annu. 1977;12 Pt 2:309-39.
7
The surgical management of Gaucher's disease.戈谢病的外科治疗
Prog Clin Biol Res. 1982;95:603-16.
8
Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
Acta Paediatr Scand Suppl. 1986;326:1-42.
9
Gaucher's disease: report of 4 cases.
Indian J Pathol Microbiol. 2007 Oct;50(4):766-8.
10
[Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].[戈谢病的酶替代疗法:利用磁共振成像监测内脏和骨骼变化]
Orv Hetil. 2003 Apr 20;144(16):749-55.

引用本文的文献

1
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review.葡萄糖脑苷脂(溶酶体神经酰胺)作为戈谢病的可靠生物标志物:叙述性综述。
Orphanet J Rare Dis. 2023 Feb 13;18(1):27. doi: 10.1186/s13023-023-02623-7.
2
Targeted Screening for Gaucher Disease in High Suspicion Patients and Clinical Profile of Screen Positives in a Large Pediatric Multispecialty Hospital.大型儿科综合专科医院对高疑似戈谢病患者的靶向筛查及筛查阳性患者的临床特征
Cureus. 2022 Oct 3;14(10):e29868. doi: 10.7759/cureus.29868. eCollection 2022 Oct.
3
Rare lysosomal disease registries: lessons learned over three decades of real-world evidence.
罕见溶酶体贮积症登记处:三十多年真实世界证据的经验教训。
Orphanet J Rare Dis. 2022 Oct 17;17(1):362. doi: 10.1186/s13023-022-02517-0.
4
Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.鞘脂贮积症相关溶血鞘脂类在癌症中的潜在作用。
Cancers (Basel). 2022 Oct 5;14(19):4858. doi: 10.3390/cancers14194858.
5
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.2123 例戈谢氏病 1 型患者的癌症风险和丙种球蛋白异常在国际戈谢氏病组织戈谢氏病注册研究中的表现。
Am J Hematol. 2022 Oct;97(10):1337-1347. doi: 10.1002/ajh.26675. Epub 2022 Aug 24.
6
Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease.戈谢氏病患者外周炎症和氧化应激生物标志物的生物学变异性。
Int J Mol Sci. 2022 Aug 16;23(16):9189. doi: 10.3390/ijms23169189.
7
Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets.鞘脂类在多发性骨髓瘤进展、耐药性中的作用及其作为治疗靶点的潜力
Front Oncol. 2022 Jun 8;12:925807. doi: 10.3389/fonc.2022.925807. eCollection 2022.
8
Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism.戈谢氏病和帕金森病伴发戈谢氏病的神经病理学特征。
Int J Mol Sci. 2022 May 23;23(10):5842. doi: 10.3390/ijms23105842.
9
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses.葡糖神经酰胺相关鞘脂是否与戈谢病患者患癌风险增加有关?综述与假说。
Cancers (Basel). 2020 Feb 18;12(2):475. doi: 10.3390/cancers12020475.
10
Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma.多发性骨髓瘤病程中血液酸性鞘磷脂酶活性降低。
Int J Mol Sci. 2019 Nov 30;20(23):6048. doi: 10.3390/ijms20236048.